We investigated the role of 68Ga-DOTATOC PET/CT in detecting somatostatin receptors (SSTRs) in 19 patients with metastatic adrenocortical carcinoma (ACC) and explored the activity of 90Y/177Lu-DOTATOC Peptide Receptor Radionuclide Therapy (PRRT).
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors
Grisanti, Salvatore;Cosentini, Deborah;Albano, Domenico;Morandi, Alessandra;Laganà, Marta;Bertagna, Francesco;Berruti, Alfredo
2019-01-01
Abstract
We investigated the role of 68Ga-DOTATOC PET/CT in detecting somatostatin receptors (SSTRs) in 19 patients with metastatic adrenocortical carcinoma (ACC) and explored the activity of 90Y/177Lu-DOTATOC Peptide Receptor Radionuclide Therapy (PRRT).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2020 March 1 - Treatment With 90Y 177Lu-DOTATOC in Patients With Metastatic Adrenocortical Carcinoma Expressing Somatostatin Receptors_compressed.pdf
solo utenti autorizzati
Tipologia:
Full Text
Licenza:
DRM non definito
Dimensione
541.28 kB
Formato
Adobe PDF
|
541.28 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
